Proteoglycan-associated glycosaminoglycan chains (GAGs)

Proteoglycan-associated glycosaminoglycan (GAG) chains are long, linear, highly negatively charged polysaccharides found abundantly in the extracellular matrix (ECM) and on cell surfaces. These chains, which include heparan sulfate, chondroitin sulfate, and dermatan sulfate, are covalently linked to core proteins to form proteoglycans, playing critical roles in maintaining tissue integrity, hydration, and regulating cell-cell and cell-matrix interactions (Source: NCBI, StatPearls). GAGs function as essential co-receptors for various growth factors, cytokines, and chemokines, thereby modulating signaling pathways involved in development, angiogenesis, and inflammation (Source: Nature Reviews Molecular Cell Biology). In disease states, GAG expression and sulfation patterns are often altered, contributing to tumor progression, chronic inflammation, and metabolic disorders like mucopolysaccharidoses (Source: NIH). Therapeutically, GAGs are targeted through the administration of exogenous GAG mimetics like heparin for anticoagulation, enzymatic degradation to enhance drug delivery using hyaluronidase, or enzyme replacement therapies to address genetic deficiencies in GAG metabolism (Source: PubChem, FDA).

Other names

GlycosaminoglycansMucopolysaccharidesGAG chainsExtracellular matrix polysaccharidesSulfated glycosaminoglycans

Drugs targeting or utilizing GAGs function by modulating protease activity (e.g., heparin-induced activation of antithrombin III), providing mechanical lubrication and visco-supplementation in joints, or through enzymatic degradation to increase tissue permeability for drug delivery. Additionally, enzyme replacement therapies provide the specific lysosomal hydrolases required to degrade accumulated GAG chains in metabolic storage disorders.